2022
Ingestible sensor system for measuring, monitoring and enhancing adherence to antiretroviral therapy: An open-label, usual care-controlled, randomised trial
Liu H, Wang Y, Huang Y, Xiong D, Shen J, Siqueiros L, Bala V, Savage G, Guerrero M, Corado K, Rosen M, Fletcher C, Daar E. Ingestible sensor system for measuring, monitoring and enhancing adherence to antiretroviral therapy: An open-label, usual care-controlled, randomised trial. EBioMedicine 2022, 86: 104330. PMID: 36372731, PMCID: PMC9782816, DOI: 10.1016/j.ebiom.2022.104330.Peer-Reviewed Original ResearchConceptsHIV RNA viral loadRNA viral loadViral loadARV concentrationsUC groupIngestible sensorUsual care groupIngestible Sensor SystemOverall satisfaction rateInstitute of HealthGroup-based trajectory modelsAdvancing Translational SciencesAntiretroviral therapyHIV clinicCare groupText remindersIS groupImproved adherenceMeasure scoresSatisfaction rateStudy participantsAntiretroviralsMental healthAdherenceNational Institute
2000
Cue‐dose Training with Monetary Reinforcement: Pilot Study of an Antiretroviral Adherence Intervention
Rigsby M, Rosen M, Beauvais J, Cramer J, Rainey P, O'Malley S, Dieckhaus K, Rounsaville B. Cue‐dose Training with Monetary Reinforcement: Pilot Study of an Antiretroviral Adherence Intervention. Journal Of General Internal Medicine 2000, 15: 841-847. PMID: 11119180, PMCID: PMC1495713, DOI: 10.1046/j.1525-1497.2000.00127.x.Peer-Reviewed Original ResearchConceptsCue-dose trainingAntiretroviral therapy regimensTherapy regimensAdherence interventionsVeterans Affairs HIV clinicsBottle openingPilot studyActive training periodAntiretroviral Adherence InterventionClinical trial sitesNear-baseline levelsAfrican AmericansHistory of heroinTraining periodAntiretroviral therapyHIV clinicMedication takingAntiretroviral drugsClinical studiesPill bottlesCD groupTransient improvementSustained improvementControl groupCocaine use